![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif)
| Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Se elabora uniendo el anticuerpo monoclonal huC242 a una sustancia tóxica que se llama maitansinoide DM4. El anticuerpo monoclonal localiza la superficie de las células cancerosas y se une a ellas, y el maitansinoide DM4 penetra en las células y bloquea su crecimiento. Es un tipo de inmunotoxina. También se llama huC242-DM4. |
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081011021306im_/http://www.nci.nih.gov/images/spacer.gif) |